Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Catherine R Aversa"'
Autor:
Mark N. Stein, Tanya B. Dorff, Oscar B. Goodman, Roby Antony Thomas, Michael H. Silverman, Matthew Guo, Catherine R Aversa, Raphael Clynes, Barbara Hickingbottom, Jolene S Shorr
Publikováno v:
Journal of Clinical Oncology. 40:TPS5097-TPS5097
TPS5097 Background: Although immune checkpoint inhibitor (ICI) monotherapy has shown limited clinical benefit in patients with metastatic castration-resistant prostate cancer (mCRPC), better outcomes have been observed with combination anti-PD-1/CTLA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36f6f4030e6a6a0bcc39abee3fb49eba
https://doi.org/10.1200/jco.2022.40.16_suppl.tps5097
https://doi.org/10.1200/jco.2022.40.16_suppl.tps5097
Autor:
Suzanne Oparil, Yiu-Fai Chen, Catherine R. Aversa, Shuang-dan Sun, Alexander G. Minchenko, Jaime Caro, Stephen K. Durham, Thomas M. Monticello, M R Swerdel, Sergio A. Lira, Maria L. Webb, Huaibin Li
Publikováno v:
American Journal of Physiology-Lung Cellular and Molecular Physiology. 273:L848-L855
Significant elevations in endothelin (ET)-1 levels accompany many diseases, but the underlying regulatory mechanisms are unclear. To investigate the in vivo regulation of human preproendothelin-1 (PPET-1), we examined the activity of the PPET-1 promo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f0d0562089bea328b6afd89c269f1c1
https://doi.org/10.1152/ajplung.1997.273.4.l848
https://doi.org/10.1152/ajplung.1997.273.4.l848